Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: Application of the systemic lupus erythematosus quality indicators

Arthritis Care and Research

Volumn 62, Issue 7, 2010, Pages 993-1001

  Schmajuk, Gabriela ^a   Yelin, Edward ^b   Chakravarty, Eliza ^a   Nelson, Lorene M ^a   Panopolis, Pantelis ^c   Yazdany, Jinoos ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; CALCIUM; STEROID; VITAMIN D;

ADULT; ARTICLE; BONE DENSITOMETRY; BONE MINERAL; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PATIENT CARE; PROPHYLAXIS; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTI-INFLAMMATORY AGENTS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCIUM; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OSTEOPOROSIS; PREDNISONE; QUALITY ASSURANCE, HEALTH CARE; VITAMIN D;

EID: 77954288455     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20150     Document Type: Article

References (46)

1. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;42:46-50.
2. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al, and the European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308.
3. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with glucocorticoids. Arthritis Rheum 2000;43:1801-8.
4. Almehed K, Forsblad d'Elia H, Kvist G, Ohlsson C, Carlsten H. Prevalence and risk factors of osteoporosis in female SLE patients: extended report. Rheumatology (Oxford) 2007;46: 1185-90.
5. Mendoza-Pinto C, Garcia-Carrasco M, Sandoval-Cruz H, Munoz-Guarneros M, Escarcega RO, Jimenez-Hernandez M, et al. Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol 2009;28:579-85.
6. Becker A, Fischer R, Scherbaum WA, Schneider M. Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage. Lupus 2001;10:809-14. (Pubitemid 34007895)
7. Medeiros MM, Silveira VA, Menezes AP, Carvalho RC. Risk factors for ovarian failure in patients with systemic lupus erythematosus. Braz J Med Biol Res 2001;34:1561-8.
8. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006; 92:4-8.
9. Trapani S, Civinini R, Ermini M, Paci E, Falcini F. Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 1998;18:45-9.
10. Sinigaglia L, Varenna M, Binelli L, Zucchi F, Ghiringhella D, Gallazzi M, et al. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women. J Rheumatol 1999;26:1280-4.
11. Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 1997;24:1922-9.
12. Kipen Y, Briganti E, Strauss B, Will R, Littlejohn G, Morand E. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Rheumatol 1999;26:310-7. (Pubitemid 29066734)
13. Hansen M, Halberg P, Kollerup G, Pedersen-Zbinden B, Horslev-Petersen K, Hyldstrup L, et al. Bone metabolism in patients with systemic lupus erythematosus: effect of disease activity and glucocorticoid treatment. Scand J Rheumatol 1998;27:197-206.
14. Jardinet D, Lefebvre C, Depresseux G, Lambert M, Devogelaer JP, Houssiau FA. Longitudinal analysis of bone mineral density in premenopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine. Rheumatology (Oxford) 2000;39:389-92. (Pubitemid 30307324)
15. Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 2001;28:102-8. (Pubitemid 32062031)
16. Kalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
17. Sels F, Dequeker J, Verwilghen J, Mbuyi-Muamba JM. SLE and osteoporosis: dependence and/or independence on glucocorticoids. Lupus 1996;5:89-92. (Pubitemid 26132219)
18. Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Chadha AB, et al. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving glucocorticoids. Rheumatology (Oxford) 2006;45:53-60.
19. Houssiau FA, Lefebvre C, Depresseux G, Lambert M, Devogelaer JP, Nagant de Deuxchaisnes C. Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996;35:244-7. (Pubitemid 26110181)
20. Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, et al, and the Systemic Lupus Erythematosus Quality Indicators Project Expert Panels. A quality indicator set for systemic lupus erythematosus. Arthritis Rheum 2009;61: 370-7.
21. MacLean CH, Saag KG, Solomon DH, Morton SC, Sampsel S, Klippel JH. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum 2004;51:193-202.
22. American College of Rheumatology. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. 2001. URL: http://www.rheumatology.org/ practice/clinical/guidelines/osteo/osteoupdate.asp.
23. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. 2008. URL: http://www.nof. org/professionals/pdfs/ NOF-Clinicians-Guide%202008.pdf.
24. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-7.
25. Cohen JW, Monheit AC, Beauregard KM, Cohen SB, Lefkowitz DC, Potter DE, et al. The Medical Expenditure Panel Survey: a national health information resource. Inquiry 1996-1997; 33:373-89.
26. Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003;12:280-6.
27. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the Systemic Lupus Erythematosus Activity Questionnaire in a large observational cohort. Arthritis Rheum 2008;59:136-43.
28. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
29. National Osteoporosis Foundation. Frequently asked questions regarding bone density testing for Medicare beneficiaries. URL: http://www.nof.org/ professionals/reimbursement/reimbursement-faqs.htm.
30. Farley JF, Blalock SJ. Trends and determinants of prescription medication use for treatment of osteoporosis. Am J Health Syst Pharm 2009;66:1191-201.
31. Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 2002; 46:3136-42.
32. Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Ramsey- Goldman R. Self-reported fractures and associated factors in women with systemic lupus erythematosus. J Rheumatol 2007;34:2018-23. (Pubitemid 47548204)
33. Pineau CA, Urowitz MB, Fortin PJ, Ibanez D, Gladman DD. Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density. Lupus 2004;13:436-41.
34. Cadarette SM, Beaton DE, Gignac MA, Jaglal SB, Dickson L, Hawker GA. Minimal error in self-report of having had DXA, but self-report of its results was poor. J Clin Epidemiol 2007; 60:1306-11.
35. US Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002;137:526-8.
36. Aizer J, Reed G, Onofrei A, Harrison MJ. Predictors of bone density testing in patients with rheumatoid arthritis. Rheumatol Int 2009;29:897-905.
37. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Relationship between quality of care and racial disparities in Medicare health plans. JAMA 2006;296:1998-2004.
38. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med 2005;353:692-700.
39. Ivers RQ, Cumming RG, Mitchell P, Peduto AJ. The accuracy of self-reported fractures in older people. J Clin Epidemiol 2002;55:452-7.
40. Ismail AA, O'Neill TW, Cockerill W, Finn JD, Cannata JB, Hoszowski K, et al, and the European Prospective Osteoporosis Study Group. Validity of self-report of fractures: results from a prospective study in men and women across Europe. Osteoporos Int 2000;11:248-54.
41. Simpson CF, Boyd CM, Carlson MC, Griswold ME, Guralnik JM, Fried LP. Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc 2004;52:123-7.
42. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004; 42:649-52.
43. Tisnado DM, Adams JL, Liu H, Damberg CL, Chen WP, Hu FA, et al. What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Med Care 2006;44:132-40.
44. Satia-Abouta J, Patterson RE, King IB, Stratton KL, Shattuck AL, Kristal AR, et al. Reliability and validity of self-report of vitamin and mineral supplement use in the Vitamins and Lifestyle Study. Am J Epidemiol 2003;157:944-54.
45. Solomon DH, Stedman M, Licari A, Weinblatt ME, Maher N, Shadick N. Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries. Arthritis Rheum 2007;57:234-9.
46. Korthuis PT, Asch S, Mancewicz M, Shapiro MF, Mathews WC, Cunningham WE, et al. Measuring medication: do interviews agree with medical record and pharmacy data? Med Care 2002;40:1270-82.